Press release
Angina Market to Reach USD 13.66 Bn by 2029, emerging at a CAGR of 5.23 percent and forecast 2023-2029
Angina Market Report Scope and Research Methodology:Our in-depth analysis is grounded in a robust research methodology, ensuring accuracy and reliability. For a closer look at our approach, please refer to the accompanying Research Methodology section.
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/221908
What are Angina Market Dynamics:
The elevated prevalence of angina, identification of therapeutic prospects, and growing investments in research and development are set to drive the Angina market's demand. Moreover, the ready accessibility of therapeutic drugs for angina, the introduction of new products, and increased awareness of various cardiovascular disorders will substantially enhance market growth during the forecast period. Nevertheless, a challenge to Angina market growth lies in the observed non-adherence to cardiovascular medications among patients with cardiovascular diseases, as they tend to opt for generic medicines instead of specific branded drugs, impacting Angina market growth during the forecast period.
Get More Information Click Here: https://www.maximizemarketresearch.com/market-report/angina-market/221908/
Angina Market Regional Insights:
North America commands a leading position in the Angina market, driven by a well-established healthcare infrastructure, widespread adoption of therapeutics, and the presence of key manufacturers. The region's high prevalence of ischemic heart disease, underscored by data from reputable sources, reinforces its dominance in the market. Ongoing clinical trials within the United States further contribute to the region's sustained growth in the Angina market.
For a deeper understanding of the Angina Market and to explore our detailed insights, please request the full report or access our complimentary sample report.
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/221908
What is Angina Market Segmentation:
by Drug Class
Beta blockers
Nitrates & Calcium Channel Blockers
Angiotensin-converting Enzyme Inhibitors
Others
by End User
Hospitals
Cardiology Centers
Others
Who are Angina Market Key Players:
1. Sanofi
2. Pfizer
3. Otsuka Pharmaceutical Co., Ltd.
4. Novartis AG
5. Merck & Co., Inc.
6. Gilead Sciences, Inc.
7. Amgen Inc.
8. Eli Lilly and Company
9. GlaxoSmithKline
10. Axus Cardium Pharmaceuticals
11. LegoChem Biosciences
12. Lee's Pharmaceutical Holdings
13. Milestone Pharmaceuticals
14. Juventas Therapeutics
15. ViroMed
16. Kuhnil Pharmaceutical
17. Johnson & Johnson
18. Bristol-Myers Squibb Company
19. Abbott
20. Bayer AG
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/221908
Table of content for the Angina Market includes:
Global Angina Market: Research Methodology
Global Angina Market: Executive Summary
Market Overview and Definitions
Introduction to the Global Market
Summary
Key Findings
Recommendations for Investors
Recommendations for Market Leaders
Recommendations for New Market Entry
3.Angina Market: Competitive Analysis
MMR Competition Matrix
Market Structure by region
Competitive Benchmarking of Key Players
Consolidation in the Market
M&A by region
Key Developments by Companies
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Market Dynamics
PORTERS Five Forces Analysis
PESTLE
Regulatory Landscape by region
North America
Europe
Asia Pacific
Middle East and Africa
South America
COVID-19 Impact
More Related Reports:
Global Picrorhiza Extract Market https://www.maximizemarketresearch.com/market-report/global-picrorhiza-extract-market/109688/
eSIM Subscription Market https://www.maximizemarketresearch.com/market-report/indian-semiconductor-market/14504/
Electric Tuk-tuks Market https://www.maximizemarketresearch.com/market-report/smart-parcel-locker-market/146818/
Drone Light Shows Market https://www.maximizemarketresearch.com/market-report/drone-light-shows-market/148130/
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 https://www.maximizemarketresearch.com
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angina Market to Reach USD 13.66 Bn by 2029, emerging at a CAGR of 5.23 percent and forecast 2023-2029 here
News-ID: 3326990 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a …
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million.
Bangladesh Ceramics Tiles Market Overview:
The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.…

Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030.
Furfural Market Overview:
The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,…

Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to …
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion.
Chemical Protective Clothing Market Overview:
The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range of…

Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR …
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion.
Prefabricated Homes Market Overview:
The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizes…
More Releases for Angina
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic angina…
Key Influencer in the Angina Pectoris Drugs Market Outlook 2025: Surging Prevale …
What market dynamics are playing a key role in accelerating the growth of the angina pectoris drugs market?
The surge in cardiovascular diseases is anticipated to kick-start the expansion of the angina pectoris drug market. The scope of cardiovascular diseases includes diverse disorders affecting the heart and blood vessels, such as stroke, coronary artery disease, hypertension, and heart failure. The rising prevalence of cardiovascular diseases (CVD) is linked to numerous elements,…
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Ar …
What Are the Projections for the Size and Growth Rate of the Angina Market?
The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a…
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina.
Angina is caused due to the built…
Angina Pectoris Drugs Market Set for Rapid Growth
Global Angina Pectoris Drugs Market: Overview
The demand within the global market for angina pectoris drugs has been rising on account of the focus given on treating medical conditions suffered by the geriatric population. The presence of a seamless industry for healthcare diagnostic and treatment has played a major role in market growth. Angina pectoris is a type of chest pain that is triggered due to reduced blood flow to…